查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1540962

2024-2032 年按组件、应用、技术、最终用户和地区分類的基因组学市场报告

Genomics Market Report by Component, Application, Technology, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2023年全球基因体学IMARC Group规模达339亿美元。全球基因组学研究的政府和私人资金不断增加、基因组学在药物发现和开发中的应用不断增加，以及人们对基因组学见解在改善健康结果方面的潜在好处的认识不断提高，推动了该市场的稳定增长。

基因组学市场分析：

主要市场驱动因素：基因定序技术的进步和对个人化医疗日益增长的兴趣推动了基因组学市场的成长。研发投资至关重要，推动基因组学市场价值上升。

主要市场趋势：基因组学中人工智慧（AI）和机器学习（ML）的整合参考了关键基因组学市场趋势，增强了基因组学市场研究能力。这种趋势有助于完善预测模型，从而实现精确的基因组学市场预测。 CRISPR基因编辑技术的采用凸显了治疗应用的重大转变，直接影响基因组学市场需求。

地理趋势：由于其先进的医疗基础设施以及对研究和创新的高度重视，北美在基因组学市场收入方面占据主导地位。在政府倡议的增加和对基因组学研究的日益关注的推动下，亚太地区显示出最快的基因组学市场成长率。这种扩张提供了多样化的基因组学市场概况，标誌着不同地区不同的成长前景。

竞争格局：基因组学领域的着名市场参与者包括 Illumina, Inc.、Thermo Fisher Scientific、QIAGEN、Agilent Technologies、Oxford Nanopore Technologies 和 CRISPR Therapeutics 等。这些实体对于确定基因组学市场前景至关重要，其竞争策略和创新对市场收入做出了重大贡献。

挑战与机会：与遗传资料相关的伦理问题以及与基因组定序相关的高成本给基因组学市场带来了挑战。然而，这些挑战也带来了创新机会，以满足不断增长的基因组学市场需求。开发具有成本效益的测序方法并建立道德准则可以进一步提升基因组学市场价值并促进基因组学市场成长。

基因组学市场趋势：

定序技术的技术创新

根据基因组学市场分析，创新进步的快节奏，特别是次世代定序 (NGS) 和 CRISPR-Cas9 基因组改变创新，是基因组学展示的重要驱动力。这些进展从根本上降低了成本、提高了速度并提高了精度，彻底改变了遗传研究，从而使基因组测序在更广泛的行业中更加可用和适用。 NGS 创新的进步使分析人员能够比已经使用的桑格测序更快、更便宜地排列 DNA 和 RNA，从而加快了基因组学的步伐。这种机械进步正在增加个人化医疗、农业基因组学和微生物基因组学等，催化了该领域内的先进企业和阴谋。

个人化医疗需求不断成长

市场的另一个重要驱动力是全球对个人化医疗的需求不断增长，即根据每个患者的独特特征量身定制医疗护理。客製化医疗在很大程度上依赖基因资料，以指导针对个别基因组成客製化特定疗法的创建，从而摆脱传统医学的通用方法，转向更准确、更有效的治疗。这也有助于提高消费者的意识，帮助他们找到「基因组市场是什么？」的答案。问题。同时，对疾病遗传原因的认识和了解的不断扩大、遗传病症发生频率的增加以及各种疾病的常规疗法的局限性也推动了日益增长的需求。在个人化医疗中使用基因组学旨在提高患者治疗效果，并透过优先考虑预防和准确治疗来提供具有成本效益的医疗保健方法，从而推动对基因组学的更多投资和研究。

临床应用和诊断的扩展

由于基因组学技术更多地用于临床应用和诊断，例如识别遗传性疾病、癌症筛检和监测传染病，该市场也在不断增长。对疾病遗传基础的进一步了解使得基因组学能够纳入临床护理，从而创造出新的诊断工具和基因测试，可以预测个体特定疾病的风险，指导治疗选择并追踪疾病进展。出现了一个问题，基因体学的需求是什么，特别是在临床应用和诊断领域？基因组学技术的进步预计将继续推动该领域的需求，扩大其在液体活检和 NIPT 等诊断领域的潜力，凸显基因组学在医疗保健和诊断革命中发挥的关键作用。

基因组学市场细分：

IMARC Group提供了每个细分市场的主要趋势分析，以及 2024-2032 年全球、区域和国家层面的预测。我们的报告根据组件、应用、技术和最终用户对市场进行了分类。

按组件划分：

产品

仪器和软体

耗材和试剂

服务

核心基因组学服务

基于 NGS 的服务

生物标誌物翻译服务

计算服务

其他的

耗材和试剂占据大部分市场份额

该报告根据组成部分提供了详细的市场细分和分析。这包括产品（仪器和软体、消耗品和试剂）、服务（核心基因组学服务、基于 NGS 的服务、生物标记翻译服务、计算服务等）。根据该报告，消耗品和试剂占据了最大的部分。

消耗品和试剂领域因其在 DNA 定序、基因编辑和样品製备等各种基因组程序中发挥的重要作用而占据市场主导地位。随着基因组学在医疗保健、农业和生物技术等领域的使用不断增加，对特定耗材和试剂的需求不断增加，导致製造商增强和扩展其产品范围。这正在促进耗材产业的发展，强调其在驱动和应用基因组学技术方面的关键作用，为市场的整体成长做出重大贡献。此外，对这些产品的强劲需求进一步巩固了该行业的主导地位，这些产品对于确保研究和临床诊断中基因组分析的准确性和可靠性至关重要。

按应用划分：

功能基因体学

表观基因组学

生物标记发现

通路分析

其他的

功能基因组学占据行业最大份额

报告还提供了基于应用程式的详细市场细分和分析。这包括功能基因组学、表观基因组学、生物标记发现、路径分析等。报告称，功能基因组学占据最大的市场份额。

功能基因组学专注于基因功能和相互作用，已成为市场的主导领域，展示了其在理解复杂的生物过程和疾病机制方面的至关重要性。在功能基因体学中利用RNA定序和CRISPR-Cas9等高通量技术可以深入研究基因表现和调控，从而推动生物医学研究和医疗保健的进步。此外，人们越来越重视探索基因组的功能特征，加上科技的快速进步，使功能基因体学成为推动整个市场成长和创新的主要力量。

按技术划分：

定序

微阵列

聚合酶炼式反应

核酸萃取与纯化

其他的

测序代表了领先的细分市场

该报告基于该技术对市场进行了详细的细分和分析。这包括定序、微阵列、聚合酶炼式反应、核酸萃取和纯化等。根据该报告，定序代表了最大的部分。

定序技术是市场的主要组成部分，因为它在破解 DNA 和 RNA 中的遗传讯息方面发挥着至关重要的作用，使其成为最大的技术领域。定序提供的关键见解透过揭示遗传变异和突变，推动了个人化医疗、基因研究和诊断应用的突出地位。此外，NGS 技术的兴起正在改变这一领域，与传统技术相比，它提供了无与伦比的速度、准确性和成本效益。 NGS 能够对基因组、外显子组和转录组进行详细分析，从而在理解复杂疾病、演化生物学和微生物基因组学方面取得进展。

按最终用户划分：

研究中心

医院和诊所

製药和生物技术公司

其他的

製药和生物技术公司在市场上表现出明显的主导地位

报告还提供了基于最终用户的详细市场细分和分析。这包括研究中心、医院和诊所、製药和生物技术公司等。报告称，製药和生物技术公司占据了最大的市场份额。

製药和生物技术公司在市场上发挥着重要作用，强调它们在推动药物开发和个人化医疗向前发展方面的重要性。这些领域应用基因组资料来识别药物的新标靶，了解疾病的遗传起源，并利用个人的遗传资料开发客製化的治疗方法。例如，全球 DNA 定序和阵列技术领域的顶级公司 Illumina Inc. 与范德比尔特大学医学中心 (VUMC) 子公司、着名的临床和基因组资料公司 Nashville Biosciences, LLC 合作，揭示了基因组发现联盟（AGD）的五名原始成员。扩展协议旨在透过进行彻底的基因组学研究和建立高品质的临床基因组资料库来加快治疗开发进程。艾伯维 (AbbVie)、安进 (Amgen)、阿斯特捷利康 (AstraZeneca)、拜耳 (Bayer) 和默克 (Merck) 将集中资源资助 250,000 个样本的测序，并利用这些资料开发药物和改进疗法。

按地区划分：

北美洲

美国

加拿大

亚太地区

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美市场领先，占据最大的基因组市场份额

该报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美是基因体学最大的区域市场。

北美由于其先进的医疗保健系统、对研发的大量投资以及顶级製药和生物技术公司的存在而拥有最大的市场份额。此外，该地区在基因组学和生物资讯学方面的先进技术以及这些因素正在为基因组学领域的发展和进步创造有利的环境。学术和研究机构与产业之间的密切合作支撑了北美在全球市场中的强势地位，从而带来了创新并设定了影响全球基因组学实践和政策的趋势。

竞争格局：

市场研究报告也对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。基因组学行业的一些主要市场参与者包括

23andMe 公司

安捷伦科技公司

拜耳公司

华大基因集团

Bio-Rad 实验室有限公司

丹纳赫公司

照明公司

牛津奈米孔技术公司

珀金埃尔默公司

无数遗传学公司

F.霍夫曼-拉罗氏有限公司

赛默飞世尔科技公司

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

该行业的主要参与者参与各种策略活动，以维护和加强其市场地位。这些企业正在研发方面进行大量投资，以推出新的基因组技术、服务和解决方案，以满足客户不断变化的需求。合作、建立合作伙伴关係和进行收购是重要的策略，使他们能够增强技术能力、进入新市场、获得新的基因组应用和智慧财产权。此外，这些顶尖公司也致力于改进其生物资讯系统，以管理和分析基因组定序产生的大量资料。这使得完整的解决方案能够帮助将基因组发现转化为临床和农业领域的进展。

基因组学市场新闻：

2023 年 10 月 30 日：23andMe, Inc 宣布与 GSK plc 达成一项新的非独家资料协议，该协议扩大了双方的合作伙伴关係，并赋予GSK 使用23andMe 数据库（最大的遗传和表型信息集合）进行药物标靶发现和其他研究的能力来自同意的参与者，可以再次联繫。根据合作协议的修订版，23andMe 将获得 2000 万美元的首期付款，以获得为期一年的非独家资料许可。

2023 年 3 月 14 日：安捷伦科技公司宣布与安捷伦合作提供完整的癌症分析解决方案。此次合作将把 SOPHiA DDM 平台与安捷伦新的仅供研究使用的 SureSelect 癌症综合基因组分析 (CGP) 检测试剂盒整合。这将使临床研究人员能够精确检测多种生物标记物，减少忽视癌症样本中关键资讯的机会。

本报告回答的关键问题

  • 2023年全球基因组市场规模有多大
  • 2024-2032年全球基因组市场的预期成长率是多少
  • 推动全球基因组学市场的关键因素是什么
  • COVID-19 对全球基因组学市场有何影响
  • 全球基因组学市场按组成部分划分是怎样的
  • 基于应用的全球基因组学市场的细分是什么
  • 基于该技术的全球基因组学市场的细分是什么
  • 基于最终用户的全球基因组学市场的细分是什么
  • 全球基因组市场的关键区域有哪些
  • 10. 全球基因体学市场的主要参与者/公司有哪些？

本报告回答的关键问题

  • 2023 年全球基因体学市场规模有多大？ 2024-2032年全球基因体学市场的预期成长率是多少？
  • 推动全球基因组学市场的关键因素是什么？
  • COVID-19 对全球基因体学市场有何影响？
  • 全球基因组学市场按组成部分划分是怎样的？
  • 根据应用，全球基因组学市场的细分如何？
  • 基于该技术的全球基因体学市场的分化是什么？
  • 基于最终用户的全球基因组学市场的细分是什么？
  • 全球基因组学市场的关键区域有哪些？
  • 谁是全球基因组学市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球基因组市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按组成部分

  • 产品
    • 市场趋势
    • 主要类型
      • 仪器和软体
      • 耗材和试剂
    • 市场预测
  • 服务
    • 市场趋势
    • 主要类型
      • 核心基因组学服务
      • 基于 NGS 的服务
      • 生物标誌物翻译服务
      • 计算服务
      • 其他的
    • 市场预测

第 7 章：市场区隔：按应用

  • 功能基因体学
    • 市场趋势
    • 市场预测
  • 表观基因组学
    • 市场趋势
    • 市场预测
  • 生物标记发现
    • 市场趋势
    • 市场预测
  • 通路分析
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依技术

  • 定序
    • 市场趋势
    • 市场预测
  • 微阵列
    • 市场趋势
    • 市场预测
  • 聚合酶炼式反应
    • 市场趋势
    • 市场预测
  • 核酸萃取与纯化
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按最终用户

  • 研究中心
    • 市场趋势
    • 市场预测
  • 医院和诊所
    • 市场趋势
    • 市场预测
  • 製药和生物技术公司
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格指标

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 23andMe, Inc.
    • Agilent Technologies, Inc.
    • Bayer Aktiengesellschaft
    • BGI Genomics Co. Ltd.
    • Bio-RAD Laboratories Inc.
    • Danaher Corporation
    • Illumina Inc.
    • Oxford Nanopore Technologies
    • PerkinElmer Inc.
    • Myriad Genetics Inc.
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A2246

The global genomics market size reached US$ 33.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 107.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.3% during 2024-2032. The market is experiencing steady growth driven by the escalating government and private funding for genomics research across the globe, the rising application of genomics in drug discovery and development, and rising awareness of the potential benefits of genomic insights in improving health outcomes.

Genomics Market Analysis:

Major Market Drivers: The genomics market growth is driven by advancements in genetic sequencing technologies and an increasing interest in personalized medicine. Investments in R&D are pivotal, pushing the genomics market value upwards.

Key Market Trends: Artificial intelligence (AI) and machine learning (ML) integration in genomics refer to the key genomics market trends, enhancing genomics market research capabilities. This trend aids in refining predictive modeling, leading to precise genomics market forecasts. The adoption of CRISPR gene editing technology highlights a significant shift in therapeutic applications, directly influencing genomics market demand.

Geographical Trends: North America dominates in terms of genomics market revenue, due to its advanced healthcare infrastructure and a strong focus on research and innovation. The Asia-Pacific region shows the fastest genomics market growth rate, propelled by increasing government initiatives and a burgeoning focus on genomics research. This expansion offers a diverse genomics market overview, signaling varied growth prospects across different regions.

Competitive Landscape: Notable market players in the genomics sector include Illumina, Inc., Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Oxford Nanopore Technologies, and CRISPR Therapeutics, among others. These entities are crucial in determining the genomics market outlook, with their competitive strategies and innovations significantly contributing to the market revenue.

Challenges and Opportunities: Ethical concerns related to genetic data and the high costs associated with genomic sequencing pose challenges in the genomics market. Yet, these challenges also unveil opportunities for innovation to meet the increasing genomics market demand. Developing cost-effective sequencing methods and establishing ethical guidelines could further bolster the genomics market value and facilitate genomics market growth.

Genomics Market Trends:

Technological innovations in sequencing technologies

According to the genomics market analysis, the fast pace of innovative advancements, especially in next-generation sequencing (NGS) and CRISPR-Cas9 genome altering innovations, serves as an essential driver for the genomics showcase. These headways have revolutionized hereditary investigation by essentially diminishing costs, expanding speed, and moving forward precision, subsequently making genomic sequencing more available and appropriate over a wide extend of businesses. Advancements in NGS innovations have empowered analysts to arrange DNA and RNA much more rapidly and cheaply than the already utilized Sanger sequencing, and as a result, have quickened the pace of genomics. This mechanical advance is increasing personalized medication, agrarian genomics, and microbial genomics, among others, catalyzing advanced ventures and intrigue within the field.

Growing demand for personalized medicine

Another important driver of the market is the rising across the globe need for personalized medicine, which customizes medical care according to each patient's unique characteristics. Customized medical treatment depends greatly on genetic data to inform the creation of specific therapies tailored to an individual's genetic composition, moving away from the generalized approach of traditional medicine to more accurate and efficient treatments. This also facilitates enhanced awareness among consumers that helps them find an answer for the "what is the genomics market?" question. Along with this, the increasing need is fueled by the expanding recognition and knowledge of the genetic causes of diseases, the increasing frequency of genetic conditions, and the limitations of conventional therapies for various illnesses. Using genomics in personalized medicine aims to enhance patient results and provides a cost-effective healthcare approach by prioritizing prevention and accurate treatment, which drives more investments and research in genomics.

Expansion in clinical applications and diagnostics

The market is also growing due to genomics technologies being utilized more for clinical applications and diagnostics, such as identifying genetic disorders, cancer screening, and monitoring infectious diseases. Improved understanding of the genetic basis of diseases has allowed for the incorporation of genomics into clinical care, resulting in the creation of novel diagnostic tools and genetic tests that can anticipate an individual's risk for specific conditions, guide treatment choices, and track disease advancement. A question arises, what is the demand for genomics, particularly in the field of clinical applications and diagnostics? Advancements in genomics technologies are anticipated to keep driving demand in this field, expanding their potential in diagnostics such as liquid biopsies and NIPT, highlighting the critical role genomics plays in revolutionizing healthcare and diagnostics.

Genomics Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on component, application, technology, and end-user.

Breakup by Component:

Products

Instruments and Software

Consumables and Reagents

Services

Core Genomics Services

NGS-Based Services

Biomarker Translation Services

Computational Services

Others

Consumables and reagents account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the component. This includes products (instruments and software, consumables and reagents), services (core genomics services, NGS-based services, biomarker translation services, computational services, and others). According to the report, consumables and reagents represented the largest segment.

The consumables and reagents sector dominates the market due to their essential role in a variety of genomic procedures including DNA sequencing, gene editing, and sample preparation. With the increased use of genomics in sectors such as healthcare, agriculture, and biotechnology, there is a rising need for specific consumables and reagents, leading manufacturers to enhance and extend their product range. This is promoting the development of the consumables industry, emphasizing its crucial role in driving and applying genomics technologies, making a substantial contribution to the market's overall growth. Moreover, the strong demand for these products, which are essential for ensuring the accuracy and reliability of genomic analyses in research and clinical diagnostics, further solidifies the dominance of this industry sector.

Breakup by Application:

Functional Genomics

Epigenomics

Biomarkers Discovery

Pathway Analysis

Others

Functional genomics holds the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes functional genomics, epigenomics, biomarkers discovery, pathway analysis, and others. According to the report, functional genomics accounted for the largest market share.

Functional genomics, which focuses on gene functions and interactions, has become the dominant area in the market, showcasing its crucial importance in comprehending intricate biological processes and disease mechanisms. Utilizing high-throughput technologies including RNA sequencing and CRISPR-Cas9 in functional genomics enables in-depth study of gene expression and regulation, leading to progress in biomedical research and healthcare. Moreover, the growing emphasis on exploring the functional characteristics of the genome, along with the quick advancements in technology, positions functional genomics as a major force driving growth and innovation in the overall market.

Breakup by Technology:

Sequencing

Microarray

Polymerase Chain Reaction

Nucleic Acid Extraction and Purification

Others

Sequencing represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the technology. This includes sequencing, microarray, polymerase chain reaction, nucleic acid extraction and purification, and others. According to the report, sequencing represented the largest segment.

Sequencing technology is the main component of the market due to its crucial role in deciphering the genetic information found in DNA and RNA, making it the largest technological segment. The critical insights provided by sequencing drive this prominence in personalized medicine, genetic research, and diagnostic applications by uncovering genetic variations and mutations. Furthermore, the rise of NGS technologies is changing this field by offering unparalleled speed, accuracy, and cost-efficiency compared to traditional techniques. NGS enables a detailed analysis of genomes, exomes, and transcriptomes, allowing for progress in comprehending complex diseases, evolutionary biology, and microbial genomics.

Breakup by End-User:

Research Centers

Hospitals and Clinics

Pharmaceutical and Biotechnology Companies

Others

Pharmaceutical and biotechnology companies exhibit a clear dominance in the market

A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes research centers, hospitals and clinics, pharmaceutical and, biotechnology companies, and others. According to the report, pharmaceutical and, biotechnology companies accounted for the largest market share.

Pharmaceutical and biotechnology companies are playing a major role in the market, emphasizing their significance in driving drug development and personalized medicine forward. These areas apply genomic data to identify novel targets for drugs, understand the genetic origins of diseases, and develop tailored treatments using individuals' genetic data. For instance, Illumina Inc., a top company in DNA sequencing and array-based technologies worldwide, partnered with Nashville Biosciences, LLC, a prominent clinical and genomic data company that is a subsidiary of Vanderbilt University Medical Center (VUMC), to reveal the five original members of the Alliance for Genomic Discovery (AGD). The extended agreement aims to quicken the treatment development process by conducting thorough genomics research and establishing a high-quality clinical genomics database. AbbVie, Amgen, AstraZeneca, Bayer, and Merck will pool their resources to fund the sequencing of 250,000 samples and can use the data for developing drugs and improving therapies.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest genomics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for genomics.

North America holds the largest market share due to its advanced healthcare system, significant investment in research and development, and the presence of top pharmaceutical and biotechnology companies. Additionally, the region's advanced technology in genomics and bioinformatics, along with these factors, is fostering a favorable environment for the development and advancement of the genomics field. North America's strong position in the global market is supported by the close collaboration between academic and research institutions with the industry, leading to innovation and setting trends that impact global genomics practices and policies.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the genomics industry include

23andMe, Inc

Agilent Technologies, Inc.

Bayer AG

BGI Group

Bio-Rad Laboratories, Inc.

Danaher Corporation

Illumina, Inc.

Oxford Nanopore Technologies

PerkinElmer, Inc.

Myriad Genetics, Inc.

F. Hoffmann-La Roche Ltd

Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Major players in the industry are involved in various strategic activities to uphold and strengthen their market presence. These businesses are making significant investments in research and development to launch new genomic technologies, services, and solutions that cater to their customers' changing needs. Working together, forming partnerships, and making acquisitions are important strategies that enable them to enhance their technological capabilities, enter new markets, and gain new genomic applications and intellectual property. Additionally, these top companies are focusing on improving their bioinformatics systems to manage and analyze the large amounts of data generated from genomic sequencing. This enables full solutions that help translate genomic findings into progress in clinical and agricultural sectors.

Genomics Market News:

October 30, 2023: 23andMe, Inc announced a fresh, non-exclusive data agreement with GSK plc that expands their partnership and grants GSK the ability to perform drug target discovery and other studies using the 23andMe database, the largest collection of genetic and phenotypic information from consenting participants that can be contacted again. According to a revision of their Collaboration Agreement, 23andMe is set to receive a $20 million initial payment for a one-year, non-exclusive data license.

March 14, 2023: Agilent Technologies, Inc. declared a collaboration with Agilent to provide a complete cancer analysis solution. The partnership will see the integration of the SOPHiA DDM Platform with Agilent's new Research Use Only SureSelect Cancer Comprehensive Genomic Profiling (CGP) Assay Kit. This will allow clinical researchers to precisely detect several biomarkers, reducing the chance of overlooking crucial information in cancer samples.

Key Questions Answered in This Report

  • 1. What was the size of the global genomics market in 2023?
  • 2. What is the expected growth rate of the global genomics market during 2024-2032?
  • 3. What are the key factors driving the global genomics market?
  • 4. What has been the impact of COVID-19 on the global genomics market?
  • 5. What is the breakup of the global genomics market based on the component?
  • 6. What is the breakup of the global genomics market based on the application?
  • 7. What is the breakup of the global genomics market based on the technology?
  • 8. What is the breakup of the global genomics market based on the end-user?
  • 9. What are the key regions in the global genomics market?
  • 10. Who are the key players/companies in the global genomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Instruments and Software
      • 6.1.2.2 Consumables and Reagents
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Core Genomics Services
      • 6.2.2.2 NGS-Based Services
      • 6.2.2.3 Biomarker Translation Services
      • 6.2.2.4 Computational Services
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Functional Genomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Epigenomics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biomarkers Discovery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pathway Analysis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Microarray
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nucleic Acid Extraction and Purification
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Research Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 23andMe, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agilent Technologies, Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 BGI Genomics Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Danaher Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Oxford Nanopore Technologies
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PerkinElmer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Roche Holding AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Genomics Market: Major Drivers and Challenges
  • Figure 2: Global: Genomics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Genomics Market: Breakup by Component (in %), 2023
  • Figure 4: Global: Genomics Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Genomics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Genomics (Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Genomics (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: North America: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: North America: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: United States: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: United States: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Canada: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: China: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: China: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Japan: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: India: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: India: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: South Korea: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Australia: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Indonesia: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Europe: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Germany: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: France: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: France: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: United Kingdom: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Italy: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Spain: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Russia: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Latin America: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Brazil: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Mexico: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Others: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Others: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Genomics Industry: SWOT Analysis
  • Figure 90: Global: Genomics Industry: Value Chain Analysis
  • Figure 91: Global: Genomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genomics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Genomics Market: Competitive Structure
  • Table 8: Global: Genomics Market: Key Players